Ep 81: IGNYTE trial (RP1 + nivo)
Melanoma Matters

Ep 81: IGNYTE trial (RP1 + nivo)

2026年2月13日32分钟

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into clinical trial interpretation and treatment efficacy (and incorrect graphs).Takeaways Clinical Trial DataTreatment Efficacy Chapters 00:00 Introduction to IGNYTE Study14:04 Response Rate and Safety Profile25:17 RNA-seq Analysis and Toxicity

播放本集

这一集暂时还没有文字稿

你仍然可以在播放器中收听。有文字稿的节目,点任意单词就能看到释义。